Fig. 7From: Bone mesenchymal stem cell extracellular vesicles delivered miR let-7-5p alleviate endothelial glycocalyx degradation and leakage via targeting ABL2Cartoon schematic of the therapeutic mechanism of bMSC-EVs delivered miR let-7-5p targeting the endothelial ABL2. The bMSC-EVs delivered let-7-5p attenuated p38MAPK activation and reduced LPS-induced endothelial glycocalyx degradation and vascular leakageBack to article page